{"id":"https://openalex.org/W1490529261","doi":"https://doi.org/10.1002/jat.2916","title":"Differential responses to JNJ\u201037822681, a specific and fast dissociating dopamine D2 receptor antagonist, in cynomolgus monkey and Sprague\u2013Dawley rat general toxicology studies: clinical observations, prolactin levels, mammary histopathology findings and toxicokinetics","display_name":"Differential responses to JNJ\u201037822681, a specific and fast dissociating dopamine D2 receptor antagonist, in cynomolgus monkey and Sprague\u2013Dawley rat general toxicology studies: clinical observations, prolactin levels, mammary histopathology findings and toxicokinetics","publication_year":2013,"publication_date":"2013-09-16","ids":{"openalex":"https://openalex.org/W1490529261","doi":"https://doi.org/10.1002/jat.2916","mag":"1490529261","pmid":"https://pubmed.ncbi.nlm.nih.gov/24105799"},"language":"en","primary_location":{"id":"doi:10.1002/jat.2916","doi":"https://doi.org/10.1002/jat.2916","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jat.2916","pdf_url":null,"source":{"id":"https://openalex.org/S81851855","display_name":"Journal of Applied Toxicology","issn_l":"0260-437X","issn":["0260-437X","1099-1263"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Applied Toxicology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041921132","display_name":"Eric J. De Waal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Eric J. de Waal","raw_affiliation_strings":["Janssen Research and Development, a division of Janssen Pharmaceutica NV, Drug Safety Sciences Department of Preclinical Project Development Turnhoutseweg 30 2340 Beerse Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research and Development, a division of Janssen Pharmaceutica NV, Drug Safety Sciences Department of Preclinical Project Development Turnhoutseweg 30 2340 Beerse Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109976366","display_name":"Maria Desmidt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Maria Desmidt","raw_affiliation_strings":["Janssen Research and Development, a division of Janssen Pharmaceutica NV, Drug Safety Sciences Department of Preclinical Project Development Turnhoutseweg 30 2340 Beerse Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research and Development, a division of Janssen Pharmaceutica NV, Drug Safety Sciences Department of Preclinical Project Development Turnhoutseweg 30 2340 Beerse Belgium","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035157409","display_name":"Sven Korte","orcid":"https://orcid.org/0000-0002-4151-9664","observed_orcids":["https://orcid.org/0000-0002-4151-9664"]},"institutions":[{"id":"https://openalex.org/I4210122233","display_name":"Covance (Germany)","ror":"https://ror.org/02phsd572","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210122233","https://openalex.org/I60638368"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sven Korte","raw_affiliation_strings":["Covance Laboratories GmbH  Kesselfeld 29 M\u00fcnster Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Covance Laboratories GmbH  Kesselfeld 29 M\u00fcnster Germany","institution_ids":["https://openalex.org/I4210122233"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003809920","display_name":"Marc O. Niehoff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122233","display_name":"Covance (Germany)","ror":"https://ror.org/02phsd572","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210122233","https://openalex.org/I60638368"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Marc Niehoff","raw_affiliation_strings":["Covance Laboratories GmbH  Kesselfeld 29 M\u00fcnster Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Covance Laboratories GmbH  Kesselfeld 29 M\u00fcnster Germany","institution_ids":["https://openalex.org/I4210122233"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067323595","display_name":"Kevan Chase","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevan Chase","raw_affiliation_strings":["Huntingdon Life Sciences Huntingdon Research Centre Woolley Road, Alconbury, Huntingdon Cambridgeshire PE28 4HS UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntingdon Life Sciences Huntingdon Research Centre Woolley Road, Alconbury, Huntingdon Cambridgeshire PE28 4HS UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013771310","display_name":"Wayne Arrowsmith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wayne Arrowsmith","raw_affiliation_strings":["Huntingdon Life Sciences Huntingdon Research Centre Woolley Road, Alconbury, Huntingdon Cambridgeshire PE28 4HS UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Huntingdon Life Sciences Huntingdon Research Centre Woolley Road, Alconbury, Huntingdon Cambridgeshire PE28 4HS UK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034252461","display_name":"Ann Lampo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Ann Lampo","raw_affiliation_strings":["Janssen Research and Development, a division of Janssen Pharmaceutica NV, Drug Safety Sciences Department of Preclinical Project Development Turnhoutseweg 30 2340 Beerse Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research and Development, a division of Janssen Pharmaceutica NV, Drug Safety Sciences Department of Preclinical Project Development Turnhoutseweg 30 2340 Beerse Belgium","institution_ids":["https://openalex.org/I137982388"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5041921132"],"corresponding_institution_ids":["https://openalex.org/I137982388"],"apc_list":{"value":3940,"currency":"USD","value_usd":3940},"apc_paid":null,"fwci":0.3968,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.6312049,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"34","issue":"9","first_page":"974","last_page":"992"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8159000277519226,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8159000277519226,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.09229999780654907,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.04149999842047691,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine-d2-receptor-antagonists","display_name":"dopamine D2 receptor antagonists","score":0.9319999814033508},{"id":"https://openalex.org/keywords/treatment-of-schizophrenia","display_name":"schizophrenia treatment","score":0.7519999742507935},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.9010000228881836},{"id":"https://openalex.org/keywords/prolactin","display_name":"prolactin","score":0.8769999742507935},{"id":"https://openalex.org/keywords/mammary-gland-histopathology","display_name":"mammary gland histopathology","score":0.9620000123977661},{"id":"https://openalex.org/keywords/species-differences","display_name":"species differences","score":0.8040000200271606},{"id":"https://openalex.org/keywords/cynomolgus-monkeys","display_name":"Macaca fascicularis","score":0.9409999847412109},{"id":"https://openalex.org/keywords/sprague-dawley-rats","display_name":"Sprague-Dawley rats","score":0.9990000128746033},{"id":"https://openalex.org/keywords/toxicokinetics","display_name":"toxicokinetics","score":0.8420000076293945},{"id":"https://openalex.org/keywords/repeated-dose-toxicity","display_name":"repeated-dose toxicity","score":0.7149999737739563}],"concepts":[{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.8345094919204712},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.58659428358078},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5829272270202637},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5607985854148865},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.5003507137298584},{"id":"https://openalex.org/C544855455","wikidata":"https://www.wikidata.org/wiki/Q1070952","display_name":"Histopathology","level":2,"score":0.48062533140182495},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.45401373505592346},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.43923425674438477},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4282761216163635},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40597233176231384},{"id":"https://openalex.org/C42407357","wikidata":"https://www.wikidata.org/wiki/Q521","display_name":"Physiology","level":1,"score":0.3950633108615875},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.25770339369773865},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2304445207118988},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008321","descriptor_name":"Mammary Glands, Animal","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D011388","descriptor_name":"Prolactin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018675","descriptor_name":"Toxicity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065127","descriptor_name":"Dopamine D2 Receptor Antagonists","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/jat.2916","doi":"https://doi.org/10.1002/jat.2916","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jat.2916","pdf_url":null,"source":{"id":"https://openalex.org/S81851855","display_name":"Journal of Applied Toxicology","issn_l":"0260-437X","issn":["0260-437X","1099-1263"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Applied Toxicology","raw_type":"journal-article"},{"id":"pmid:24105799","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24105799","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of applied toxicology : JAT","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W62870477","https://openalex.org/W1600588219","https://openalex.org/W1870623700","https://openalex.org/W1948611034","https://openalex.org/W1966829289","https://openalex.org/W1977072704","https://openalex.org/W1978186008","https://openalex.org/W1978751446","https://openalex.org/W1981399315","https://openalex.org/W1981805188","https://openalex.org/W1982962238","https://openalex.org/W1998386370","https://openalex.org/W1999514770","https://openalex.org/W2003883483","https://openalex.org/W2010764223","https://openalex.org/W2014396251","https://openalex.org/W2025671425","https://openalex.org/W2026136738","https://openalex.org/W2032457469","https://openalex.org/W2033428309","https://openalex.org/W2036283124","https://openalex.org/W2042569343","https://openalex.org/W2042978265","https://openalex.org/W2043463703","https://openalex.org/W2047741256","https://openalex.org/W2053259280","https://openalex.org/W2060274995","https://openalex.org/W2067496987","https://openalex.org/W2068057735","https://openalex.org/W2069849124","https://openalex.org/W2074183548","https://openalex.org/W2087310251","https://openalex.org/W2090891087","https://openalex.org/W2099576957","https://openalex.org/W2099723479","https://openalex.org/W2100936684","https://openalex.org/W2119704634","https://openalex.org/W2124092559","https://openalex.org/W2132178461","https://openalex.org/W2132980997","https://openalex.org/W2134284299","https://openalex.org/W2148775403","https://openalex.org/W2150382103","https://openalex.org/W2154017841","https://openalex.org/W2159130276","https://openalex.org/W2159614453","https://openalex.org/W2164875032","https://openalex.org/W2167218562","https://openalex.org/W2589302021","https://openalex.org/W4240517607"],"related_works":["https://openalex.org/W2154017841","https://openalex.org/W2132178461","https://openalex.org/W2014396251","https://openalex.org/W2134284299","https://openalex.org/W2086304372","https://openalex.org/W2082777188","https://openalex.org/W2053749611","https://openalex.org/W2048580544","https://openalex.org/W2081907358","https://openalex.org/W2312259022"],"abstract_inverted_index":{"JNJ-37822681":[0,58],"is":[1],"a":[2,25],"potent,":[3],"specific":[4],"and":[5,36,46,66,87,140],"fast":[6,119],"dissociating":[7,120],"dopamine":[8],"D2":[9],"receptor":[10],"antagonist":[11],"intended":[12],"for":[13],"the":[14,55,71,108,118,123,161,222,225,230,237,246],"treatment":[15,43],"of":[16,27,42,61,107,122,189,239],"schizophrenia.":[17,103],"Its":[18],"nonclinical":[19],"toxicological":[20],"profile":[21],"was":[22,44,114],"investigated":[23],"in":[24,33,54,59,70,100,138,154,172,180,203,221,243],"series":[26],"general":[28],"repeat":[29],"dose":[30,187],"toxicity":[31],"studies":[32,194],"cynomolgus":[34,231],"monkeys":[35],"Sprague-Dawley":[37,247],"rats.":[38],"The":[39,104,191],"maximum":[40],"duration":[41],"9":[45],"6":[47],"months,":[48],"respectively.":[49],"Interspecies":[50],"differences":[51],"were":[52,127,136,170,176,207],"noted":[53,171,209],"response":[56],"to":[57,95,110,130,146],"terms":[60],"extrapyramidal":[62],"(EPS)-like":[63],"clinical":[64,78],"signs":[65,79,113],"prolactin-mediated":[67],"tissue":[68,149,168],"changes":[69,150,169],"mammary":[72,162,166],"gland.":[73],"Monkeys":[74],"showed":[75,144,233],"severe":[76],"EPS-like":[77,112],"such":[80],"as":[81],"abnormal":[82,84],"posture,":[83],"eye":[85],"movements":[86],"hallucination-like":[88],"behavior":[89],"at":[90,210,217],"relatively":[91,185],"low":[92],"exposures":[93,211],"compared":[94],"those":[96,215],"associated":[97],"with":[98,102,182],"EPS":[99],"patients":[101,181],"high":[105,186],"sensitivity":[106],"monkey":[109,192,232],"JNJ-37822681-induced":[111],"unexpected":[115],"based":[116],"on":[117],"properties":[121],"compound.":[124],"Rats,":[125],"however,":[126],"not":[128,196],"prone":[129],"EPS.":[131],"Elevated":[132],"serum":[133],"prolactin":[134],"levels":[135,175,188],"found":[137],"rats":[139,143,204],"monkeys.":[141,173],"While":[142],"slight":[145],"moderate":[147],"prolactin-related":[148],"upon":[151],"histopathological":[152],"examination":[153],"all":[155],"studies,":[156],"which":[157],"among":[158],"others":[159],"affected":[160],"gland,":[163],"only":[164,177,208],"minor":[165],"gland":[167],"Prolactin":[174],"slightly":[178],"increased":[179],"schizophrenia":[183],"receiving":[184],"JNJ-37822681.":[190],"toxicology":[193],"did":[195],"provide":[197],"an":[198],"exposure-based":[199],"safety":[200],"margin,":[201],"while":[202],"adverse":[205,241],"effects":[206],"considerably":[212],"higher":[213],"than":[214,245],"achieved":[216],"efficacious":[218],"plasma":[219],"concentrations":[220],"clinic.":[223],"Overall,":[224],"available":[226],"data":[227],"suggest":[228],"that":[229],"better":[234],"predictivity":[235],"towards":[236],"nature":[238],"JNJ-37822681-associated":[240],"events":[242],"humans":[244],"rat.":[248]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}